Spain In Vitro Fertilization Market Size & Outlook
Global Market
Related Markets
Spain in vitro fertilization market highlights
- The Spain in vitro fertilization market generated a revenue of USD 1,114.6 million in 2025 and is expected to reach USD 1,600.1 million by 2033.
- The Spain market is expected to grow at a CAGR of 4.49% from 2026 to 2033.
- In terms of segment, frozen nondonor was the largest revenue generating procedure type in 2025.
- Fresh Donor is the most lucrative procedure type segment registering the fastest growth during the forecast period.
In vitro fertilization market data book summary
| Market revenue in 2025 | USD 1,114.6 million |
| Market revenue in 2033 | USD 1,600.1 million |
| Growth rate | 4.49% (CAGR from 2026 to 2033) |
| Largest segment | Frozen nondonor |
| Fastest growing segment | Fresh Donor |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
| Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
Other key industry trends
- In terms of revenue, Spain accounted for 3.9% of the global in vitro fertilization market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany in vitro fertilization market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,608.0 million by 2033.
The success rates for regular ART cycles in Spain ranged from 8% to 27%, with the rate varying based on the age of the patient. Younger patients typically had higher success rates compared to older patients. It is important to note that success rates can also be influenced by factors such as the cause of infertility, the quality of embryos, and the specific protocols used.
Furthermore, for cycles using donor eggs, the success rates were generally higher in Spain. The average success rate for donor-egg cycles in Spain was around 37%. This higher success rate can be attributed to the use of young and healthy donor eggs, which can improve the chances of a successful pregnancy.
According to a study published in March 2021 by Health Europe, between 2011 and 2021, there has been a significant decline in the number of annual births in Spain, with a decrease of 29%. This decline in the birth rate has raised concerns about the country's population dynamics and future demographic trends.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
In Vitro Fertilization Market Scope
In Vitro Fertilization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Boston Scientific Corp | View profile | 48,000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | www.bostonscientific.com |
| Vitrolife AB ADR | View profile | 1,116 | Box 9080, Gothenburg, Sweden, 400 92 | www.vitrolife.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| The Cooper Companies Inc | View profile | 15,000 | 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583 | www.coopercos.com |
| Genea Biomedx | View profile | 101-250 | Sydney, New South Wales, Australia, Oceania | www.geneabiomedx.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | www.cookmedical.com |
Spain In Vitro Fertilization Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.
Frozen Nondonor was the largest segment with a revenue share of 51.62% in 2025.
Horizon Databook has segmented the Spain in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.
The success rates for regular ART cycles in Spain ranged from 8% to 27%, with the rate varying based on the age of the patient. Younger patients typically had higher success rates compared to older patients. It is important to note that success rates can also be influenced by factors such as the cause of infertility, the quality of embryos, and the specific protocols used.
Furthermore, for cycles using donor eggs, the success rates were generally higher in Spain. The average success rate for donor-egg cycles in Spain was around 37%. This higher success rate can be attributed to the use of young and healthy donor eggs, which can improve the chances of a successful pregnancy.
According to a study published in March 2021 by Health Europe, between 2011 and 2021, there has been a significant decline in the number of annual births in Spain, with a decrease of 29%. This decline in the birth rate has raised concerns about the country's population dynamics and future demographic trends.
- Spain In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
- Fresh Nondonor
- Frozen Nondonor
- Fresh Donor
- Frozen Donor
- Spain In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
- Fertility Clinics
- Hospitals and Other Settings
Reasons to subscribe to In Vitro Fertilization Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Fertilization Market Outlook databook
- Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain In Vitro Fertilization Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Spain In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Spain In Vitro Fertilization Market, 2021-2033 (US$M)
Spain in vitro fertilization market statistics, by procedure type, 2021-2033 (US$M)
